Press Releases - 2017

2017

 

2016

 

2015

 

2014

 

2013

 

 

7/13/17

Statement from AMCP CEO Susan A. Cantrell, RPh CAE, on House Passage of FDARA 

AMCP commends the House for its passage yesterday of H.R. 2430, the Food and Drug Administration Reauthorization Act (FDARA) of 2017. 

7/12/17

AMCP-Supported Bill to Create Safe Harbor for Pre-FDA-Approval Product Communications Examined in House Subcommittee on Health Hearing 

Washington, D.C., July 12, 2017 — The U.S. House Energy and Commerce Committee’s Subcommittee on Health held a hearing today on the “Pharmaceutical Information Exchange (PIE) Act of 2017” (H.R. 2026). 

6/23/17

AMCP Partnership Forum Attendees Create Action Plans to Advance Value-Based Contracting

Diverse stakeholders representing managed care pharmacy, provider groups, integrated delivery systems and the biopharmaceutical industry this week developed key strategies to enable the expansion of “value-based contracting.”

6/7/17

Cantrell Comments on House Energy & Commerce Committee Action on PIE Act  

Pre-FDA-approval communications took an important step forward in today’s discussion of H.R. 2026. 

6/5/17

Journal of Managed Care & Specialty Pharmacy Supplement Examines Frameworks for Assessing Value of Oncology Treatments 

To address escalating drug costs, health care payers increasingly are adopting benefit designs that aim to identify and pay for medications based on their value. The June issue of the Journal of Managed Care & Specialty Pharmacy features a special supplement comparing existing “value frameworks” used in such benefit designs to assess high-cost oncology treatments. 

5/1/17

AMCP Releases Multi-Stakeholder Findings to Drive Value and Outcomes in Oncology 

Increased collaboration, improved decision-making support tools and greater use of value-based contracting are among the recommendations to address the accelerating pace of oncology products coming to market each year, according to proceedings from the AMCP Partnership Forum: Driving Value and Outcomes in Oncology

4/28/17

AMCP Foundation Holds Successful Campaigns to Support Future Research, Help Low-Income Residents in Denver 

The AMCP Foundation fulfilled a significant part of its philanthropic mission last month with two successful giving campaigns.

4/26/17

JMCP Research Highlight: Hypoclycemia, A1C Control, and Adherence Affect Costs for Patients with Type 2 Diabetes in a Real-World Population 

While improved adherence to diabetes medications is associated with higher drug costs, it also is associated with lower inpatient, outpatient and emergency room costs, according to a study in this month’s

4/10/17

AMCP Applauds Introduction of the “Pharmaceutical Information Exchange (PIE) Act of 2017” 

 The Academy commends Rep. Brett Guthrie (R-KY) for introducing H.R.2026, the "Pharmaceutical Information Exchange (PIE) Act of 2017."

3/30/17

AMCP Foundation Announces Recipients of 2017 National P&T Competition, Best Poster Contests 

Denver, Colo., March 30, 2017 — The AMCP Foundation is proud to announce winners of its 17th Annual National Student Pharmacist Pharmacy & Therapeutics (P&T) Competition and 2017 Best Poster Contests for student pharmacists, residents or fellows, and graduate students. Winning the P&T Competition was the University of North Carolina Eshelman School of Pharmacy. Winner of the Best Student Pharmacist Poster was Arianna Kee; Best Resident or Fellow Poster was Kameron Kelly, PharmD; and Best Graduate Student Poster was Sanket Shah, MBBS.

3/30/17

AMCP Foundation Board of Trustees Swears in New Member, Summerpal Kahlon, MD

Denver, Colo., March 30, 2017 — The Academy of Managed Care Pharmacy (AMCP) Foundation is pleased to announce the addition of Summerpal Kahlon, MD, to its Board of Trustees.

3/30/17

Managed Care Pharmacy Leaders Honored at Academy of Managed Care Pharmacy/AMCP Foundation Awards Dinner

Denver, Colo., March 30, 2017 — The Academy of Managed Care Pharmacy and AMCP Foundation honored some of managed care pharmacy’s brightest leaders last night at the Annual Award Dinner. Eight awards were presented at the gala event held March 29 as part of the AMCP Managed Care & Specialty Pharmacy Annual Meeting in Denver, Colorado.

3/28/17

Academy of Managed Care Pharmacy Opens AMCP Managed Care & Specialty Pharmacy Annual Meeting

Denver, Colorado, March 28, 2017 — Four thousand managed care pharmacy professionals and stakeholders from across the country have traveled to Denver, Colorado, this week for the Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting.

3/8/17

AMCP Members Urge Congress, Administration to Include Comprehensive Pharmacy Benefit in Reform Plan 

Managed care pharmacy professionals have the expertise necessary to help lawmakers develop policies for an effective pharmaceutical benefit under any new health care reform bill that may emerge in the weeks and months ahead. That was the key message delivered over the past two days by the Academy of Managed Care Pharmacy (AMCP) at its Annual Legislative Days.

2/23/17

AMCP Foundation Executive Director Paula Eichenbrenner Named ‘Young & Aspiring’ Association Executive by Association TRENDS Magazine   

Eichenbrenner was one of five individuals selected for this prestigious national award, presented since 1998 to the brightest rising stars of the association community. 

2/3/17

This Month’s Journal of Managed Care & Specialty Pharmacy Focuses on Optimizing Outcomes in Oncology 

February’s themed issue of the Journal of Managed Care & Specialty Pharmacy examines challenges that managed care pharmacists face in administering oncology therapies, including considerations around patient-reported outcomes and the role of caregivers.

1/25/17

Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) Announces Addition of Apobiologix to Consortium

The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) is pleased to announce the addition of a new participating organization, Apobiologix.

1/18/17

AMCP Praises FDA’s Guidance on Communications Between Biopharmaceutical Companies and Population Health Decision Makers; Guidance Largely Aligns With AMCP Recommendations  

The Academy commends the FDA for its release today of draft guidance clarifying how biopharmaceutical companies and population health decision makers can proactively share clinical and economic information on both FDA approved products as well as emerging therapies awaiting FDA approval. 

1/1/17

AMCP Releases Consensus Recommendations Proposing the Creation of a Safe Harbor for Preapproval Information Exchange (PIE)    

The Academy has released a set of consensus recommendations to allow biopharmaceutical companies to proactively share clinical and economic information with population health decision makers on emerging therapies in advance of FDA approval, an area that is significantly restricted by current federal laws and FDA regulations. 


 

Content for class "break" Goes Here